RECENT WEBINARS
The Future Of Gene Therapy Production: Enriching Full Capsids, Reducing Costs
Explore how intensified upstream processing enriches full AAV capsids, reduces impurities, and lowers manufacturing costs. Learn how extended culture duration drives better outcomes.
Developing Your Risk-Based Approach To Single-Use System Integrity
Explore how a holistic approach to single-use system integrity can strengthen contamination control, improve operational efficiency, and meet evolving regulatory expectations in manufacturing.
Optimize DNA Clearance In High-Salt, GMP-Grade Purification Processes
Explore how salt-active endonucleases overcome DNA clearance challenges in viral vector purification by digesting down to 3–5 nucleotides and performing reliably in high-salt conditions.
The Case For Optimized And Excipient GMP Cell Culture Solutions
Learn how optimized, customizable formulations and Excipient GMP manufacturing streamline development, ensuring quality and consistency for a de-risked path to the clinic.
Unlocking Allogeneic Cell Therapy: Exploring Durable Approaches
Learn how genome engineering and iPSCs are being used to overcome the critical challenges of durability and host immune clearance in both clinical and preclinical settings for allogeneic cell therapies.
Enhancing Non-Viral CAR T Manufacturing With Electroporation And Microbubble T Cell Isolation
Unlock superior non-viral CAR T manufacturing outcomes by combining gentle microbubble T cell isolation with advanced electroporation. See how this approach boosts cell viability and transfection efficiency.
In-Line PAT Solutions For cGMP Environments
Learn how real-time monitoring and PAT platforms can streamline bioprocessing, reduce testing delays, and improve decision-making across upstream and downstream workflows.
Development Of An Off-The-Shelf γδ T-Cell Platform
Learn how γδ T cells are being engineered into scalable, off-the-shelf therapies with enhanced safety and potency, as well as discover strategies to overcome immunological barriers.
From Plasmids To Cell-Free DNA Using Megabulb DNA
Discover a non-viral approach for T cell engineering that overcomes limitations of viral transduction. Learn how a novel single-stranded DNA template and CRISPR technology deliver a scalable solution.
Break The Cell Therapy Manufacturing Bottleneck With Day-0 Transduction, Day-3 Harvest
Discover the potential of T1 cell-derived nanoparticles (CDNPs) to accelerate T-cell activation. See how CDNPs’ unique mechanism of mimicking physiological immune stimulation positions them for broad use.
Evolving Gene Editing For Rare Disease Drug Development
Explore how scalable gene editing platforms are advancing therapies for ultra-orphan conditions, with insights into manufacturing models, regulatory strategies, and clinical approaches.
Cell Bank And Scale Up Strategies For MSC And Exosome Manufacturing
Discover how effective cell banking and scale-up strategies can reduce risk and cost in advanced therapy manufacturing. Learn practical ways to meet increasing cell and exosome quantity needs.
Compliance To Confidence: Annex 1 For Small-Batch, High-Value Production
Get strategies for meeting the updated GMP Annex 1 in small-batch aseptic filling. Learn about contamination control, quality management, and equipment design for high-value liquid and powder products.
Supply Resiliency For Bioprocessing Amid Global Volatility
Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.
Achieving Flexibility In T Cell Manufacturing - Adaptation Of Standardized Processes
Explore how scalable CAR-T manufacturing impacts T cell biology and therapy efficacy, as well as how standardized processes can support diverse production needs while preserving critical characteristics.
Process Intensification Strategies For Smarter Biomanufacturing
Explore how biopharma leaders are using process intensification to modernize facilities, cut costs, and increase yield with practical strategies and real-world case studies.
Genetically Modified MSCs For The Treatment Of GvHD
Discover how genetically engineered MSCs are significantly advancing GvHD treatment. Learn about preclinical success with CXCR4-IL10-MSCs and the process for scaling up their GMP production.
Avoid The Wrecking Ball: Targeted Solutions For Struggling Trials
In this presentation, our expert panel introduces the concept of scaffolding — a targeted reinforcement strategy designed to strengthen trials from the inside out.
Optimizing Aseptic Processing With Isolator Technology
Discover how pharmaceutical isolators optimize operations, achieve higher sterility assurance, and meet stringent regulatory requirements. Learn about design principles, validation, and VHP cycles.
Filtration Unfiltered: Technology To Meet New Bioprocessing Challenges
Explore how filtration strategies are adapting to diverse molecule pipelines, regulations, and sustainability targets with insights into process intensification and the technologies shaping the future.
How Digital Cleaning Validation Can Simplify Audit Readiness And Improve Compliance
Discover how to enhance audit readiness and improve compliance by shifting to a digital cleaning validation program. Learn to determine worst-case products and maximum safe carryover limits.
Ensuring Compliance In Gene Therapy Trials: IRB And IBC Views
Explore ethical and regulatory challenges in neurological gene therapy trials, with expert insights on IRB/IBC collaboration, consent protocols, and oversight for vulnerable populations.
Streamlining Vaccine Purification: Techniques For Modern Modalities
Explore cutting-edge chromatography techniques accelerating vaccine purification across diverse modalities, with case studies on HPV, Malaria, and COVID-19.
Advancing Non-Viral Gene Editing With Enhanced Post-Electroporation Performance
Non-viral gene editing is a powerful method for cell therapy. Learn how to address key challenges like cell viability and thermal damage with an innovative approach designed to improve performance.
Mobilizing Science, Partnership, And Capability To Develop A Gene Therapy In 14 Months
Hear how one family, driven by urgency, partnered with AAV experts to develop a treatment for their daughter’s ultra-rare neurodegenerative disorder, NEDAMSS, in just 14 months.
From Flow Data To GMP Decisions: How Express Modes Standardize QC
Standardizing QC in flow cytometry is now possible with embedded digital guidance. Discover how Express Modes help ensure consistency, compliance, and faster insight in cell and gene therapy workflows.
Advances In Pediatric Transplant: T-Cell Depleted Haploidentical Experience
Explore how T cell–depleted haplo-HSCT is expanding donor options for pediatric patients, with insights into clinical outcomes, immune recovery, and evolving strategies.
Real-Time Monitoring Of Higher-Order Structure Of RNAs
Learn how a new biophysical characterization strategy can enhance RNA therapeutic candidate screening and formulation development through a deeper understanding of RNA structure under native conditions.
Extractables, Leachables, And Risk: Ensuring Safety In Pharma Manufacturing
This session is designed for teams developing new products, optimizing processes, or preparing regulatory submissions, and will provide practical tools for a better approach to E&L management.
Solving Fragmentation: Future-Proofing The Advanced Therapy Supply Chain
Whether you are preparing for your first clinical shipment or scaling for global distribution, this conversation provides strategies to streamline operations, improve reliability, and deliver better patient outcomes.